4//SEC Filing
Conn Morgan 4
Accession 0001062993-24-017718
CIK 0001850119other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:58 PM ET
Size
7.3 KB
Accession
0001062993-24-017718
Insider Transaction Report
Form 4
Conn Morgan
Chief Finanical Officer
Transactions
- Award
Common Stock
2024-10-14+60,148→ 60,148 total - Award
Stock Option (right to buy)
2024-10-14+360,890→ 360,890 totalExercise: $1.48Exp: 2034-10-14→ Common Stock (360,890 underlying)
Footnotes (2)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on October 14, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
- [F2]The option vests 25% on October 14, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0001974124
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:58 PM ET
- Size
- 7.3 KB